Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0HKGDZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Bevacizumab fluoresceine 13
|
|||||
| Synonyms |
Bevacizumab fluoresceine 13
Click to Show/Hide
|
|||||
| Organization |
Cristal Therapeutics.; Utrecht University.; TBD Pharmatech.; Lonza AG.; Maastricht University.; University of Glasgow.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2.3
|
|||||
| Structure |
|
|||||
| Antibody Name |
Bevacizumab
|
Antibody Info | ||||
| Antigen Name |
Vascular endothelial growth factor A (VEGFA)
|
Antigen Info | ||||
| Payload Name |
Fluoresceine 13
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Click Chemistry Conjugation.
|
|||||